✦ LIBER ✦

PD-48 Pemetrexed-based concurrent chemoradiotherapy (CRT)for locally advanced or metastatic non-small cell lung or esophageal cancer: A phase I dose-escalating study

✍ Scribed by Seiwert, T.; Connell, P.; Mauer, A.; Hoffman, P.; George, C.; Szeto, L.; Salgia, R.; Kayitalire, L.; Haraf, D.; Vokes, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent chemoradiotherapy with tomoth

✍ Alessandra Bearz,Emilio Minatel,Imad Abu Rumeileh,Eugenio Borsatti… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 243 KB

A randomised phase II study of pemetrexe

✍ Dittrich, Christian; Papai-Szekely, Zsolt; Vinolas, Nuria; Sederholm, Christer; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 517 KB

Toxicity and Response of Pemetrexed Plus

✍ J.H. Heinzerling; R.S. Hughes; R. Govindan; J.D. Bradley; J.D. Schiller; G. Peng 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A Randomized Phase II Study of Pemetrexe

✍ Schuette, Wolfgang H.W.; Gröschel, Andreas; Sebastian, Martin; Andreas, Stefan; 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 534 KB

Phase I dose-escalation study of oral vi

✍ Krzakowski, M.; Bennouna, J.; Dansin, E.; Kowalski, D.; Hiret, S.; Penel, N.; Fa 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 316 KB

Vinorelbine plus low-dose cisplatinum wi

✍ Ralph Winterhalder; Simone Deschler-Marini; Christine Landmann; Roger Kann; Jako 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 77 KB